Fred Middleton
InvestorManaging Director at Sanderling Ventures
FoundedAltor BioscienceCalcimedicaHCW BiologicsStereotaxisViacyte
About
Middleton has over thirty years of experience in biotechnology and biomedical industries in both corporate operating and institutional venture capital roles, working as investor, manager and director in over 20 biomedical ventures at Sanderling since 1988.
Deals · 2
HCW BiologicsBoard seat
via Sanderling Ventures · filed Oct 2020 · $16M raise
CalciMedica SubsidiaryBoard seat
via Sanderling Ventures · filed May 2020 · $17.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Sanderling Ventures
Benjamin F. McGraw III
Venture Partner at Sanderling Ventures
Michael Dixon
Principal at Sanderling Ventures
Paulette Taylor
General Counsel & Principal at Sanderling Ventures
Peter McWilliams
Venture Partner at Sanderling Ventures
Pierre Beauparlant
Venture Partner at Sanderling Ventures
Robert G. McNeil
Founding Partner at Sanderling Ventures
Timothy Mills
Managing Director at Sanderling Ventures
Timothy Wollaeger
Managing Director Emeritus at Sanderling Ventures